Navigation Links
Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
Date:10/14/2009

ST. PETERSBURG, Fla., Oct. 14 /PRNewswire/ -- In the United States, a woman is diagnosed with breast cancer every three minutes, according to the American Cancer Society. Except for skin cancers, breast cancer is the most frequently diagnosed cancer among woman.

To help fight this disease, eMed-ID, the world's first emergency medical information device franchise, will donate $10 for every pink Personal Health Records (PHR) wristband sold to raise awareness during Breast Cancer Awareness Month. This pink wristband, as well as other optional styles, contains a USB device that has an individual's personal health history, medications taken, allergies, etc. eMed-ID's proprietary device is designed to expedite emergency responders' treatment of a patient who may not be able to communicate their personal medical information. It also helps consolidate health records and make them accessible to healthcare providers when needed.

"Individuals with breast cancer, as well as survivors of breast cancer, find themselves seeing numerous physicians and managing multiple medications and courses of treatment throughout their illness and beyond," said Lonnie Helgerson, CEO, eMed-ID Franchising, LLC. "As a result, we believe strongly that this group of individuals should have their personal health records consolidated and with them on e-Med-ID's PHR device in case of emergency or other circumstances that require medical history at the ready."

The eMed-ID package is $69.95 and includes the PHR USB device, four eMed-ID caregiver cards, two eMed-ID In Case of Emergency (I.C.E.) refrigerator cards and a bound report. In addition, eMed-ID is the only medical identification product that also provides customers with an optional legally-binding healthcare surrogate, HIPAA release and living will. The company also partners with the "Silver Alert" program, modeled after "Amber Alert," to help protect an increasing number of citizens with cognitive impairments. The pink wristband is just one option. Others include blue wristbands, credit cards and keychains.

"We are honored to join the fight on breast cancer and contribute a portion of the sales of our popular pink wristbands to breast cancer research," said Helgerson. "We've built the eMed-ID business to provide local communities, including people of all ages, with medical services and products that improve the quality of healthcare and save lives. This is just another way to become involved in the health care community and help individuals and families manage their own health."

Consumers can purchase the eMed-ID pink wristband, as well as other products, through eMed-ID's franchise network in cities located throughout the United States. To find your eMed-ID representative, visit www.emed-id.com/find.htm or call 1-866-607-0411.

For those interested in starting their own business, eMed-ID represents an ideal franchise opportunity given the current economic conditions by providing interested franchisees a low-cost of entry. The company is offering candidates the opportunity with a total investment of less than $10,000. Three-year term financing is available to qualified candidates for approximately $38 a week.

Area Representative opportunities are available starting at $29,950 to those interested in recruiting franchisees and owning a minimum protected territory of 200,000 residents. In addition, the franchise provides Veterans a $2,450 discount and a three percent reduction on financing interest.

About eMed-ID

Headquartered in St. Petersburg, FL, eMed-ID is the world's first emergency medical device franchise currently with 22 franchisees operating in several states including Florida, Indiana, Texas, Oregon, Arizona, North Carolina and Montana. The home-based, low cost franchise offers consumers a suite of emergency medical devices to protect their family and friends. For additional product or franchising information, please call 866.607.0411 or log onto www.eMed-ID.com.

    Media Contact:
    Kim Ryan
    Fish Consulting
    770.932.0695
    kryan@fish-consulting.com

SOURCE eMed-ID


'/>"/>
SOURCE eMed-ID
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):